OOIR: Observatory of International Research

Papers

(The median citation count of Digestive and Liver Disease is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Beyond inflammation: Expanding the horizon on vascular risk assessment in inflammatory	72
Comment on ``Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignancies''	69
Relationship between recipient/donor features and liver stiffness measurement in the first year after liver transplantation	68
Mapping the hepatic mtDNA genomic landscape in patients with MASLD: The Era of GPT-4 Artificial Intelligence	60
Identification of causes and patterns of albumin structural damages in commercial formulations	58
Assessment of sarcopenia with ultrasound-based measurements in patients with liver cirrhosis and correlation with clinical outcomes	55
Cardiometabolic risk factors and clinical course of liver cirrhosis	52
Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly	48
Comment on ``Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based survey''	48
Full Title Page /Editorial Board	48
Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP	46
Letter to the editor: Comment on “Synergistic effect of oral exclusive enteral nutrition and biologic in induction therapy for adult Crohn disease”	42
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study	40
Renal cell carcinoma metastasis as an atypical cause of gastrointestinal bleeding	40
OC.04.7 EFFECT OF MTOR INHIBITION ON EXOSOMES ISOLATED FROMPC CELLS WITH DIFFERENT KRAS MUTATIONS	39
OC.09.5 ADVANCING IN ERCP: THE SLIM DUODENOSCOPE AS A CORNERSTONE FOR CHALLENGING ANATOMIES – INSIGHTS FROM AN ITALIAN CASE SERIES	39
OC.22.3 THREE-YEAR OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY BY OBESITY CLASS	38
OC.09.9 BALANCING RISKS AND BENEFITS: EVALUATING THE SAFETYAND EFFICACY OF CHOLANGIOPANCREATOSCOPY IN ELDERLY AND FRAIL POPULATIONS	38
OC.17.5 ENDOSCOPIC VACUUM THERAPY (EVT) FOR THE MANAGEMENT OF UPPER GASTROINTESTINAL TRACT LEAKS AND DEFECTS: A RETROSPECTIVE STUDY FROM ATERTIARY REFERRAL CENTER IN NEARLY 100 PATIENTS	37
T.03.5 EVALUATION OF RECTALWALL THICKNESS MEASUREMENT SENSITIVITY VIA TRANSABDOMINAL ULTRASOUND TO ASSESS MUCOSAL ACTIVITY IN ULCERATIVE COLITIS: COULD THIS BE A USEFUL NON-INVASIVE TOOL? A PRELIMINAR	36
T.08.4 PRELIMINARY DATA FROM AN ONGOING MULTICENTER STUDY: EVALUATION OF THE DIAGNOSTIC ACCURACY OF CHATGPT-4 IN THE RECOGNITION AND CLASSIFICATION OF ESOPHAGEAL VARICES	36
T.10.4 APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD) SAFETY PROFILE: PILOT DATA	35
Ileocaecal Crohn's disease. To resect or not to resect, is that the question?	35
Liver transplantation following HCC rupture and long-term immunotherapy: a case report	34
OC.06.4 DEMOGRAPHIC DIFFERENCES IN LEFT-TO-RIGHT SHIFT OF COLON CANCER OVER 25 YEARS: RESULTS FROM ROBUST ANALYSIS OF CANCER REGISTRY DATA	34

Other than Insulin Antidiabetic Treatment Associates with Better Status of Frailty in Patients with Cirrhosis and Type 2 Diabetes on Waiting List for Liver Transplantation	34
How macronutrients and pancreatic enzyme supplements dose variability affect fat, protein and starch absorption in children with cystic fibrosis	34
OC.04.1 SURGERY IN HIGH-RISK PAEDIATRIC CROHN'S DISEASE TREATED WITH UP-FRONT ANTI-TNF AGENTS AND LONG-STANDING BIOLOGIC THERAPY	33
Impact of laparoscopic liver resection for access to the waiting list of a single regional liver transplant center in southern Italy: entry and dropout flows’ analysis	32
Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studies	32
Impact of ISO score on oncological outcomes and survival in liver transplant candidates with hepatocellular carcinoma	32
Fully automated approach of machine learning combined with deep learning: How to predict the onset of major cardiovascular events in NAFLD patients	32
Application of Machine Learning Model-3P to Predict Portal Hypertension in Patient with Hepatocellular Carcinoma	31
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network	31
T.12.2: THE LEVELS OF AFP, PIVKA-II AND GPC-3 SERUM BIOMARKERS AT DIAGNOSIS CORRELATE WITH HCC CLINICAL-PATHOLOGICAL FEATURES AND WITH OVERALL SURVIVAL	31
T.04.5: COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOWED NO DIFFERENCES IN IMMUNOGENICITY OR TREATMENT PERSISTENCE AT ONE YEAR	31
T.04.4: CLINICAL OUTCOME AFTER CROHN'S DISEASE-RELATED SURGERY DIFFERENT FROM ILEO-COLONIC RESECTION	31
Recurrent IgG4 cholangitis after liver transplantation: Back to the future	30
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: A single-center experience	30
T.03.5 CLINICAL AND LABORATORY FEATURES OF ANEMIA IN SUBJECTS SUFFERING FROM COELIAC DISEASE	29
T.01.6 THE EFFICACY OF SIX-FOOD ELIMINATION DIET IS LOWER DURING POLLEN SEASON IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS SENSITIZED TO POLLENS	29
T.01.2 SEVERE OBESITY IMPAIRS POST-REFLUX SWALLOW-INDUCED PERISTALTIC WAVE INDEX REGARDLESS OF ACID EXPOSURE	28
T.08.8 IMPACT OF METFORMIN ON THE INCIDENCE OF HUMAN CHOLANGIOCARCINOMA IN DIABETIC PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS	28
V.01.7 COMPLETE INTRA-PERITONEAL MALDEPLOYMENT OF A LAMS DURING EUS-GEA FOR MGOO: RESCUE RETRIEVAL WITH PERITONEOSCOPY THROUGH NOTES	27
T.10.4 INTESTINAL ULTRASONOGRAPHY PROFILING OF PATIENTS WITH CROHN'S DISEASE PREDICTS LONG TERM CLINICAL REMISSION	27
OC.11.3 LAPAROSCOPIC HELLER DOR IS AN EFFECTIVE TREATMENT FOR ESOPHAGEAL-GASTRIC JUNCTION OUTFLOW OBSTRUCTION	27
An unusual lesion of the gallbladder mimicking gallbladder carcinoma	26
The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease	26
T.11.7 THE PROGNOSTIC ROLE OF RADIOMICS IN GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMORS	26
OC.03.4 PREVALENCE OF AUTOIMMUNE ATROPHIC GASTRITIS IN A GASTROENTEROLOGICAL SETTING BY USING AN EXTENSIVE SCREENING STRATEGY VS A CASE FINDING STRATEGY	26
Author's Reply: “NRF2 in cancer: An insufficiently explored and controversial research area”	25
BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOFACITINIB-TREATED HUMAN BIOPSIES FROM ACTIVE ULCERATIVE COLITIS PATIENTS TO PREDICT CLINICAL RESPONSE (THE AVATAR STUDY)	25
OC.01.3: EVENING CHRONOTYPE CORRELATES WITH SEVERITY OF FUNCTIONAL DYSPEPSIA AND AFFECT SLEEP QUALITY	25
T.05.10 CLINICAL HETEROGENEITY OF ADULT COELIAC DISEASE ACCORDING TO THE AGE AT ONSET: AN ITALIAN MULTICENTRIC STUDY	25
OC.12.5 MYOSTEATOSIS IS NOT ASSOCIATED WITH COMPLICATIONS OR SURVIVAL IN HCC PATIENTS UNDERGOING TRANS ARTERIAL EMBOLIZATION	25
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC	24
Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome - acute kidney injury	24
Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients	24
Venous hepatic aneurysms	24
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease	24
V.04.5: OVER THE SCOPE CLIPS: A RESCUE THERAPY FOR DUODENAL PERFORATION DUE TO BILIARY STENT MIGRATION	24
ABCA8: A potential therapeutic target in the treatment of colorectal cancer?	23
Multiple small intestinal ulcers with SLCO2A1 mutation in a Chinese patient	23
Does HLA-G play a role in PBC?	23
OC.08.4: ARTIFICIAL INTELLIGENCE TOOLS PREDICT EOSINOPHILIC ESOPHAGITIS IN ADULTS REPORTING DYSPHAGIA: DEVELOPMENT, EXTERNALVALIDATION, AND SOFTWARE CREATION FOR POINT-OF-CARE USE	23
PC.01.7 EUS-GUIDED FINE-NEEDLE BIOPSY OF SOLID LESIONS WITH OR WITHOUT MACROSCOPIC ON-SITE EVALUATION (MOSE): A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL	22
Deep learning for histopathological diagnosis of esophageal squamous cell carcinoma in biopsies: A multicenter analysis	22
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU	22
Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus	22
Comment on “Effect of vessels that encapsulate tumor clusters (VETC) and different stages of hepatocellular carcinoma after hepatectomy”	22
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study	22
Do glucagon-like peptide-1 based therapies alter the risk of late-onset inflammatory bowel disease?	22
Safety of same day discharge after Zenker's diverticulum peroral endoscopic myotomy	21
Clinical prediction models in minimal hepatic encephalopathy: how far can they go?	21
Digital single-operator cholangioscopy in diagnostic and therapeutic bilio-pancreatic diseases: A prospective, multicenter study	21

Cannulation rates and technical performance evaluation of commericially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis	21
Establishing a nomogram for predicting necrotizing enterocolitis in premature infants: A retrospective multicenter cohort study	21
NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension	20
ACNMD26-463: ENDOSCOPIC ULTRASOUND WITH DETECTIVE FLOW IMAGING (DFI) FOR PREDICTING PANCREATIC NEUROENDOCRINE TUMOUR GRADE: SINGLE CENTRE EXPERIENCE	20
Outcomes and predictors of delayed endoscopic biliary drainage for severe acute cholangitis due to choledocholithiasis in an intensive care unit	20
Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study	20
ACNMD26-293: ENDOSCOPIC ULTRASOUND SHEAR-WAVE ELASTOGRAPHY FOR DIAGNOSIS OF CHRONIC PANCREATITIS IN AWESTERN POPULATION: PRELIMINARY RESULTS FROM THE SWEG STUDY	20
Autoimmune atrophic gastritis and coeliac disease: A case-control study	20
Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth	20
ACNMD26-387: ALBUMIN AS A PREDICTOR OF LONG-TERM POST-TIPS SURVIVAL	20
ACNMD26-295: REDEFINING SURGICAL RISK IN CROHN’S DISEASE: THE PERSISTENT ROLE OF NOD2 GENOTYPE IN THE BIOLOGIC ERA	19
ACNMD26-163: DUPILUMAB IS EFFICACIOUS REGARDLESS OF ENDOSCOPIC PHENOTYPE: POST HOC ANALYSIS OF THE LIBERTY EOE TREET STUDY	19
ACNMD26-613: POSTOPERATIVE HIGH-RESOLUTION MANOMETRY IN CLINICAL PRACTICE: VALIDATION OF THE PADOVA CLASSIFICATION	19
ACNMD26-630: ENDOSCOPIC ULTRASOUND-GUIDED GASTROENTEROSTOMY TO TREAT PATIENTS WITH BENIGNGASTRIC OUTLET OBSTRUCTION: A MULTICENTER SERIES	19
ACNMD26-82: PREMEDICATION FOR IMPROVING VISIBILITY DURING ESOPHAGOGASTRODUODENOSCOPY: A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL	19
ACNMD26-346: DO WE REALLY NEED TWO DIFFERENT ESOPHAGEAL DGBI?	19
Accuracy of automated 3D biliary tract reconstruction compared to ERCP to assess Bismuth-Corlette classification in patients with perihilar cholangiocarcinoma	18
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma	18
Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis	18
Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9/LCN-2 complex	18
Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel disease	18
Advancing endoscopic papillectomy: Outcomes and insights from a single-center learning experience	18
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial	18
Mesenteric panniculitis is associated with cardiovascular risk-factors: A case-control study	18
OC.10.1 MASLD AND FIB4 ARE INDEPENDENT PREDICTORS OF MAJOR ADVERSE LIVER OUTCOMES AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: FINDINGS FROM A SINGLE-CENTER COHORT USING AI-DRIVEN MACHINE LEARNING	17
OC.05.5 HUMAN EXTRACHROMOSOMAL CIRCULAR DNA (ECCDNA) IS A NOVEL BIOMARKER IN INFLAMMATORY BOWEL DISEASE	17
Diagnostic yield of whole exome sequencing in adult-onset cholestatic liver disease	17
OC.17.3 PERORAL ENDOSCOPIC MYOTOMY FOR SPASTIC ESOPHAGEAL MOTILITY DISORDERS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS	17
OC.20.5 REAL-TIME ELASTOGRAPHY AS A PREDICTOR OF INTESTINAL WALL FIBROSIS IN CROHN’S DISEASE	17
More advanced presentation but similar survival for hepatocellular carcinoma in HIV positive compared to HIV-negative patients: a retrospective cohort analysis	17
Assessment of sarcopenia improves the prediction of post-TIPS mortality in older adult patients with cirrhosis	17
OC.22.1 PREVALENCE OF SARCOPENIA IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OBSERVATIONAL STUDY IN A TERTIARY CARE CENTRE	17
Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) in patients with anatomical portal contraindication to liver transplantation: feasibility and clinical implication	17
OC.05.1 ROLE OF RADIOMICS IN PREDICTING THE DEGREE OF INTESTINAL FIBROSIS IN PATIENTS WITH CROHN’S DISEASE	16
T.10.7 WELCOME TO THE APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD): A PROSPECTIVE OBSERVATIONAL REGIONAL DATABASE ON THE SAFETY AND EFFECTIVENESS OF ALL LICENSED THERAPIES. WHAT IS THE ENRO	16
Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, an	16
Cecal Trichuris trichiura infection discovered by colonoscopy	16
Full Title Page /Editorial Board	16
BOC.01.2 TRANSORAL SEPTOTOMY VERSUS Z-POEM IN THE TREATMENT OF ZENKER DIVERTICULUM: A MULTICENTER CASE-MATCHED COMPARATIVE STUDY	16
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease	16
OC.22.4 “REALWORLD” PERCUTANEOUS ENDOSCOPIC GASTROSTOMY MANAGEMENT IN ENDOSCOPY CENTRES	16
Pancreatic steatosis and post-operative pancreatic fistula after pancreatectomy	16
Delineating unique MASH-endothelial cells in metabolic dysfunction-associated steatotic liver disease using single-cell lensing	16
OC.14.3 THE ANTHELMINTIC DRUG RAFOXANIDE PROMOTES OXIDATIVE STRESS AND VDAC1 OPENING LEADING TO MITOCHONDRIAL DYSFUNCTION IN COLORECTAL CANCER CELLS	16
Comparison of ciprofol–alfentanil and propofol–alfentanil sedation during bidirectional endoscopy: A prospective, double-blind, randomised, controlled trial	16
Environmental enteropathy and inflammatory bowel disease are not mutually exclusive	16
Author's Reply: Comment on “A systematic review and meta-analysis: the role of potassium-competitive acid blockers in endoscopy-negative reflux disease”	16
TREM1 facilitates the development of gastric cancer through regulating neutrophil extracellular traps-mediated macrophage polarization	15
ACNMD26-537: DIAGNOSTIC ACCURACY AND SAFETY OF A NEWLY DESIGNED FRANSEEN-TIP NEEDLE WITH MACROSCOPIC ON-SITE EVALUATION FOR SOLID LESIONS: A MULTICENTER STUDY	15
ACNMD26-305: FLIP PANOMETRY FREQUENTLY IDENTIFIES ABNORMALITIES IN PATIENTS WITH DYSPHAGIA AND NORMAL OR INCONCLUSIVE MANOMETRY GUIDING CLINICAL MANAGEMENT	15
Lower rate of pancreatobiliary complications after sludge and microlithiasis pancreatitis compared to gallstone pancreatitis	15
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis	15
ACNMD26-543: SYMPTOM BURDEN AND QUALITY OF LIFE IN ROME IV POSITIVE UNINVESTIGATED DYSPEPSIA: INSIGHTS FROM THE GUESS MULTICENTRE STUDY	15
ACNMD26-13: BASELINE ANTI-αVβ6 PREDICTS 12-MONTH REMISSION IN ULCERATIVE COLITIS	15
V.02.7 THROUGH THE LAMS INTERVENTION AFTER ENDOSCOPIC ULTRASOUND-GUIDED RESIDUAL GALLBLADDER DRAINAGE AS RESCUE TREATMENT IN NON SURGICAL CANDIDATE WITH RECURRENT BILIARY ABDOMINAL PAIN	15
VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway	15
ACNMD26-338: LONG-TERM COHORTANALYSIS OF HBV BASIC CORE PROMOTER, PRE-CORE, AND CORE REGION HETEROGENEITY	15
ACNMD26-292: TEXTBOOK OUTCOMES OF EUS-GUIDED HEPATICOGASTROSTOMY ACCORDING TO INDICATION AND PRESENTING ANATOMY: A PROSPECTIVE COHORT STUDY	15
A new tool for rapid evaluation of endoscopic ultrasound through the needle biopsy in pancreatic cystic neoplasm	14
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review	14
T.03.1 IMPACT OF GENDER ON CLINICAL MANIFESTATIONS OF COELIAC DISEASE AT THE TIME OF DIAGNOSIS AND FOLLOW-UP	14
T.12.7 IS ONE PASS ENOUGH FOR THE DIAGNOSIS OF THE PANCREATIC MASSES DURING EUS-FNB? A PROSPECTIVE STUDY	14
T.04.3 USING A NEW ELECTROCAUTERY LUMEN APPOSING METAL STENT TO PERFORM AN EUS-GUIDED GASTROENTEROSTOMY IN TREATMENT OF GASTRIC OUTLET OBSTRUCTION	14
T.05.2 DO WE NEED THREE DIFFERENT TYPES OF ESOPHAGOGASTRIC JUNCTION?	14
Author's reply: “Comment on “The association analysis between exposure to volatile organic compounds and fatty liver disease in US Adults””	14
OC.03.6 DUODENAL GASTRIC METAPLASIA AND DUODENAL NEUROENDOCRINE NEOPLASMS: TRUE CAUSALITY OR SIMPLE COINCIDENCE?	14
OC.11.6 UPPER ESOPHAGEAL SPHINCTER PARAMETERS IN EOSINOPHILIC ESOPHAGITIS: NEW PERSPECTIVES	14
T.07.1 NATURAL HISTORY AND CLINICAL IMPACT OF NON-NEOPLASTIC PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA	14
Safety and immunogenicity of booster dose in patients with chronic liver disease	14
The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune checkpoint regulation in hep	14
Clinical Significance of histologic healing in IBD: Evidence from randomized controlled trials (RCT) and real world (RW) data	14
IgA-autoantibodies to Histone 2B and alcohol-associated liver disease (ALD): Another drop in the ocean of potential useful biomarkers	14
PC.01.6 EVOLUTION OF THE RESIDENT MICROBIOTA IN GASTRIC CARCINOGENESIS	14
OC.16.2 OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY IN THE ELDER POPULATION	14
OC.03.1 THE SAME FACTORS IMPACT DIFFERENTLY ON TIME TO DEATH IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE COHORT STUDY	14
OC.11.3 THERAPEUTIC EFFECTS OF MELATONIN IN COMBINATION WITH LACTOBACILLUS RHAMNOSUS GG IN PEDIATRIC FUNCTIONAL ABDOMINAL PAIN DISORDERS: A PILOT CLINICAL STUDY	14
T.01.10 ITALIAN SOCIETY FOR DIGESTIVE ENDOSCOPY (SIED), ITALIAN ASSOCIATION OF HEALTHCARE TECHNICAL OPERATORS (ANOTE) AND ACCREDITATION ASSESSMENT: EVALUATION OF MANAGEMENT AND ORGANIZATIONAL EFFICACY	14
T.04.8 A MULTICENTRIC SURVEY ON THE AVAILABILITY AND USE OF ANESTHESIOLOGIST-DIRECTED CARE IN GASTROINTESTINAL ENDOSCOPY	13
Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement	13
Where does capsule endoscopy fit in the diagnostic algorithm of small bowel intussusception?	13

Tofacitinib in ulcerative colitis – In the era of precision medicine’	13
T.12.6 ALARMING CORRELATION BETWEEN MULTIDRUG-RESISTANT BACTERIOBILIA AND MORBIDITY AFTER PANCREATIC SURGERY	13
Clinical utility of a targeted panel sequencing for the diagnosis of chronic hereditary liver diseases in adult patients	13
OC.01.1 EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY	13
Role of rare and common variants in the diagnosis of adults with cryptogenic liver and lipid disorders	13
Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes	13
OC.05.5 ENDOSCOPIC TISSUE ACQUISITION DURING ERCP IN BILIARY STENOSIS: RETROSPECTIVE ANALYSIS OF CASES FROM A TERTIARY REFERRAL HOSPITAL	13
SIRT5 rs12216101 T>G variant is associated with oxidative stress and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease	13
PC.01.3 LONG-TERM OUTCOME OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM THE PEDIATRIC IBD PORTO GROUP OF ESPGHAN	13
T.04.6: ERECTILE AND PROSTATIC DYSFUNCTION IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE	13
OC.12.1 QUANTITATIVE HBV/HDV MARKERS HELP TO DISTINGUISH DIFFERENT CLINIC/VIROLOGIC PHASES OF CHRONIC HEPATITIS DELTA	13
Detection of coronary artery disease in liver transplant recipients: does stress echocardiography still have a role?	12
OC.07.6: THE BURDEN OF PSYCHIATRIC MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW WITH META-ANALYSIS	12
T.03.4: ENDOSCOPIC EVALUATION OF NEWLY REPORTED INTESTINAL WALL THICKENING: PRELIMINARY RESULTS	12
Prevalence and Characterization of Resistance Profiles of “Unusual” HCV Subtypes in Italy within the Italian Resistance Network Vironet C	12
Comment on “Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota”	12
BOC.02.8: DEFINING DIAGNOSTIC ULTRASONOGRAPHIC PARAMETERS IN ULCERATIVE COLITIS: A LONGITUDINAL PROSPECTIVE MULTICENTER STUDY	12
Immune dysregulation and porto-sinusoidal vascular disorder: A novel association with BENTA disease	12
Performance of different approaches to difficult biliary cannulation in endoscopic retrograde cholangiopancreatography: A systematic review and network meta-analysis	12
Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma	12
T.04.7: ADHERENCE TO MEDITERRANEAN DIET AND DIET QUALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER, OBSERVATIONAL CASE-CONTROL STUDY	12
OC.01.7: AN EMILIN1-ALTERED MICROENVIRONMENT PROMOTES TUMORCELL PROLIFERATIONAND LYMPHATIC DYSFUNCTION IN GASTRIC CANCER	12
BOC.01.7: EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF SEVERE AND SEVERE-COMPLICATED CLOSTRIDIOIDES DIFFICILE INFECTION: REPORT FROM A LARGE-VOLUME FMT CENTER	12
OC.02.5: METABOLIC DISORDERS IN COELIAC DISEASE AFTER GLUTENFREE DIET	12
Efficacy and safety of cold snare polypectomy for sessile serrated polyps ≥ 10 mm: A systematic review and meta-analysis	12
OC.17.3: HOT VS COLD EMR: AWELL-KNOWN DUALISM IN A NORTHEASTERN ITALIAN EXPERIENCE	12
Rapidly progressive EBV-positive DLBCL arising from a duodenal diverticulum	12
Author's reply: “Predictors for the development of diabetes mellitus following acute pancreatitis”	12
Prevalence of undiagnosed celiac disease in the adult general population of Italy in 1990: Baseline reference for testing current increasing incidence?	12
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging concept	12
Intractable diarrhea in infancy and molecular analysis: We are beyond the tip of the iceberg	12
Author's Reply: “Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?”	12
V.03.5: CHOLANGIOSCOPIC DIAGNOSIS OF AN INTRADUCTAL PAPILLARY BILIARY NEOPLASM: A RARE CAUSE OF BILIARY STRICTURE	12
Comparison of metabolic alterations, hepatic and cardiovascular damage between primary NAFLD and HIV-associated NAFLD: Role of low visceral adiposity	12
Cure after surgery for hepato-pancreato-biliary cancers: A systematic review	12
Integrating AI in medicine: Lessons from Chat-GPT's limitations in medical imaging	12
Utility of novel composite index in predicting the prognosis of total neoadjuvant therapy for locally advanced rectal cancer: A multicenter real-world cohort study	12
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension	12
The role of miRNA in IBS pathogenesis, diagnosis and therapy: The latest thought	12
The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors	11
Comment on: Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study	11
Whether and when to biopsy coeliac patients: A never-ending story	11
OC.15.2 ENDOSCOPIC TREATMENT OF PANCREATIC DUCT DISRUPTION AND CYSTIC DUCT LEAK USING CYANOACRYLATE: A CASE SERIES	11
OC.14.5 THERAPEUTIC MODULATION OF GUT MICROBIOME TO TREAT IMMUNE-CHECKPOINT INHIBITORS-RELATED DIARRHEA AND COLITIS: EXPERIENCE OF A MICROBIOME CLINIC	11
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis	11
Endoscopic ultrasound-guided drainage of pancreatic collections with dedicated metal stents: A nationwide, multicenter, propensity score-matched comparison	11
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance	11
Delayed ERCP in the setting of severe acute cholangitis—How much delay is “Delayed”?	11
A journey from marginality to routine and beyond: single center experience with DCD utilization for liver transplantation in Italy	11
Proton pump inhibitor dosing patterns are less than optimal among new referrals to an outpatient gastroenterology clinic	11
OC.07.9 RISK FACTORS AND INCIDENCE OF DYSPLASIA/ ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH BARRETT’S ESOPHAGUS: DATA FROMA PROSPECTIVE, INTERNATIONAL, OBSVERVATIONAL STUDY - THE IOBER PROJECT	11
OC.01.6 MOLECULAR SIGNATURE OF ESOPHAGEAL STRICTURE AFTER CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION: PRELIMINARY INSIGHTS FROM A PILOT STUDY	11
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota	11
OC.19.3 CLINICAL RELEVANCE OF POSITIVE MOLECULAR STOOL TESTING FOR INTESTINAL PATHOGENS IN DIFFERENT GASTROINTESTINAL DISORDERS	11
OC.14.4 EXPLORING MICROBIOTA-IMMUNE INTERACTIONS IN SHORT BOWEL SYNDROME AND CROHN’S DISEASE IN A MODEL OF HUMAN MICROBIOTA ASSOCIATED MICE	11
Evolving trends in liver cirrhosis: etiology, complications and comorbidities	11
Characterization of transcriptional and functional CD8 T cell heterogeneity to design individualized correction strategies for chronic HBV infection	11
T.04.4 TOO MANY COUCH POTATOES AMONG MIDDLE-AGED INFLAMMATORY BOWEL DISEASE PATIENTS! FINDINGS FROM THE “BE-FIT-IBD-2” STUDY ON PATIENT-REPORTED PHYSICAL ACTIVITY LEVELS EXAMINING THEIR INTERACTIONS W	11
OC.02.20 SPLIT THE SPLIT: EFFICACY AND TOLERABILITY OF THE ASYMMETRIC SPLIT PREPARATION SCHEME WITH AVERY LOW VOLUME INTESTINAL PREPARATION: RANDOMIZED, SINGLEBLIND, PARALLEL-GROUP CLINICAL TRIAL	11
T.01.10 SELF-EXPANDING METAL STENT FOR REFRACTORY VARICEAL BLEEDING: AN UMBRELLA REVIEW WITH THE SYNTHESIS OF THE BEST EVIDENCE	11
Is it time to introduce health coaching in inflammatory bowel disease management?	11
T.02.7 ANTHROPOMETRIC MEASUREMENTS, BODY COMPOSITION AND PREDICTIVE ROLE OF PHASE ANGLE IN WEIGHT LOSS AFTER BARIATRIC ENDOSCOPY: RESULTS FROM TWO SINGLE-CENTER, RANDOMIZED TRIALS	11
BOC.03.3 PERFORMANCE OF THREE ENDOSCOPIC GASTROPLASTY TECHNIQUES IN DIFFERENT OBESITY CLASSES. RESULTS AT 18 MONTHS FOLLOW-UP FROM A SINGLE CENTER, RANDOMIZED TRIAL	11
Antonio Ascione, 1941 - 2023: in memoriam	10
Circulating interleukin-32 levels are associated with arterial hypertension in individuals at risk of NAFLD	10
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction (UDFF) in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease	10
Quantification of plasma HDV RNA in untreated and Bulevirtide-treated patients with CHD: a comparison between Robogene 2.0, Eurobioplex and Altostar	10
OC.15.2 SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM	10
Skin injuries prevention during TIPS creation: use of “alert levels” and “trigger levels” in a high volume TIPS referral hospital (˃20 procedures/year)	10
Factors affecting treatment decisions for endoscopically resected low- and high-risk malignant colorectal polyps in a screening setting	10
To be or NOD 2 be: The role of NOD2 in predisposing patients with cirrhosis towards infections	10
OC.14.4 FEASIBILITY AND SAFETY OF A NEW DEDICATED BILIARY STENT FOR EUS-GUIDED HEPATICO-GASTROSTOMY: THE FIT STUDY	10
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH	10
OC.08.10: PROXIMAL ESOPHAGEAL IMPEDANCE BASELINE INCREASES THE YIELD OF IMPEDANCE-PH AND IS ASSOCIATED WITH RESPONSE TO PPIS IN CHRONIC COUGH PATIENTS	10
OC.06.1: THE POSSIBILITY OF OBTAINING GOOD QUALITY AND QUANTITY RNA FROM EUS-FNA SAMPLES OF PANNENS: A PROSPECTIVE STUDY	10
T.09.4 POTENTIAL COELIAC DISEASE HIDDEN BY ISOLATED HYPERTRANSAMINASAEMIA IN A 8-YEAR-OLD GIRL	10
Editorial Board	10
Liver and spleen stiffness measure by transient elastograghy: a promising tool for the clinical management of patients after Fontan-type surgery circulation	10
Exploring the interplay between sarcopenia, liver and cardiovascular damage in non-cirrhotic masld patients: a genetic perspective	10
A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma	10
Multi-modal endoscopic artificial intelligence system improving classification of colorectal subepithelial lesions: a multicenter study	10
Comment on: “Measured glomerular filtration rate based on iohexol: Towards an application in liver transplantation.”	10
OC.11.4: LIVER TRANSPLANT IN ACLF AND ALD: AN EFFECTIVE OPTION WITH LIMITED ACCESS? PRELIMINARY RESULTS OF A SINGLE CENTER EXPERIENCE	10
Title Page	10
T.06.6: CLINICAL AND GENETIC CHARACTERISTICS OF LYNCH SYNDROME: A RETROSPECTIVE STUDY IN A LARGE COHORT OF PATIENTS	10
V.02.3 E.D.G.E.: AS SOON AS POSSIBLE COULD BE A “DANGEROUS” OPTION	10
Liver function is a predictor of survival in patients with hepatocellular carcinoma in best supportive care	10
Determinants of liver stiffness measurements changes in Metabolic dysfunction-Associated Steatotic Liver Disease: insights from two cohorts	10
To re-transplant, or not to re-transplant, that is the question	10
Author's reply: Comment on “comparative efficacy of different bowel preparations for colonoscopy: A network meta-analysis"	10
OC.13.6 POST-ERCP ACUTE PANCREATITIS IN LIVER TRANSPLANTED PATIENTS: A CASE-CONTROL STUDY	10
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII	9
Safety evaluation of extracorporeal shockwave lithotripsy for pancreatic stones: Experience based on a large chronic pancreatitis cohort	9
MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenteration	9
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability	9